Jul 30, 2026 04:07PM
Jul 30, 2026 04:05PM
May 5, 2026 04:05PM
Feb 23, 2026 04:05PM
Jan 12, 2026 08:32AM
Jan 12, 2026 08:30AM
Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
Nov 3, 2025 04:05PM
Aug 5, 2025 04:05PM
May 6, 2025 04:05PM
Feb 24, 2025 04:05PM
Jan 15, 2025 08:32AM
Jan 15, 2025 08:30AM
Nov 7, 2024 04:05PM Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
Aug 6, 2024 04:05PM
May 7, 2024 04:05PM
Feb 27, 2024 04:05PM
Feb 1, 2024 09:25AM
Jan 19, 2024 04:49AM
Jan 18, 2024 06:10PM
Dec 21, 2023 08:30AM Myriad Genetics (MYGN) Announces CFO Resignation
Dec 21, 2023 08:30AM
Nov 6, 2023 04:05PM
Sep 18, 2023 08:00AM
Aug 3, 2023 04:05PM
May 3, 2023 04:05PM
Feb 28, 2023 04:05PM
Feb 28, 2023 04:05PM Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight
Nov 1, 2022 09:11AM
Nov 1, 2022 09:10AM
Nov 1, 2022 09:10AM
Nov 1, 2022 09:05AM
Nov 1, 2022 09:05AM
Aug 4, 2022 07:05AM
Aug 4, 2022 07:05AM Myriad Genetics Reports Second Quarter Financial Results
Jun 23, 2022 04:06PM
Jun 23, 2022 04:05PM
Jun 23, 2022 04:05PM
May 26, 2022 06:30PM
May 26, 2022 06:30PM
May 5, 2022 09:00AM
May 5, 2022 09:00AM Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
May 3, 2022 04:17PM
May 3, 2022 04:15PM
May 3, 2022 04:15PM
Mar 14, 2022 07:05AM
Mar 14, 2022 07:05AM
Mar 14, 2022 07:05AM
Mar 11, 2022 07:05PM Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
Mar 11, 2022 07:05PM

1,173,829 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All